Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 87

1.

Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033.

Heinrich MC, Rankin C, Blanke CD, Demetri GD, Borden EC, Ryan CW, von Mehren M, Blackstein ME, Priebat DA, Tap WD, Maki RG, Corless CL, Fletcher JA, Owzar K, Crowley JJ, Benjamin RS, Baker LH.

JAMA Oncol. 2017 Jul 1;3(7):944-952. doi: 10.1001/jamaoncol.2016.6728.

PMID:
28196207
2.

Clinical features and outcomes of 20 patients with abdominopelvic desmoplastic small round cell tumor.

Angarita FA, Hassan S, Cannell AJ, Dickson BC, Gladdy RA, Swallow CJ, Gupta A, Blackstein ME, McCart JA.

Eur J Surg Oncol. 2017 Feb;43(2):423-431. doi: 10.1016/j.ejso.2016.08.017. Epub 2016 Oct 4.

PMID:
27890349
3.

Results of Resection for Recurrent or Residual Retroperitoneal Sarcoma After Failed Primary Treatment.

Hamilton TD, Cannell AJ, Kim M, Catton CN, Blackstein ME, Dickson BC, Gladdy RA, Swallow CJ.

Ann Surg Oncol. 2017 Jan;24(1):211-218. doi: 10.1245/s10434-016-5523-6. Epub 2016 Aug 23.

PMID:
27554502
4.

Histopathologic Features of Prognostic Significance in High-Grade Osteosarcoma.

Chui MH, Kandel RA, Wong M, Griffin AM, Bell RS, Blackstein ME, Wunder JS, Dickson BC.

Arch Pathol Lab Med. 2016 Aug 23. [Epub ahead of print]

PMID:
27552092
5.

Toward Observation as First-line Management in Abdominal Desmoid Tumors.

Burtenshaw SM, Cannell AJ, McAlister ED, Siddique S, Kandel R, Blackstein ME, Swallow CJ, Gladdy RA.

Ann Surg Oncol. 2016 Jul;23(7):2212-9. doi: 10.1245/s10434-016-5159-6. Epub 2016 Mar 28.

PMID:
27020588
6.

Efficacy of denosumab in joint preservation for patients with giant cell tumour of the bone.

Traub F, Singh J, Dickson BC, Leung S, Mohankumar R, Blackstein ME, Razak AR, Griffin AM, Ferguson PC, Wunder JS.

Eur J Cancer. 2016 May;59:1-12. doi: 10.1016/j.ejca.2016.01.006. Epub 2016 Mar 15.

PMID:
26990281
7.

Trabectedin for inoperable or recurrent soft tissue sarcoma in adult patients: a retrospective cohort study.

Angarita FA, Cannell AJ, Abdul Razak AR, Dickson BC, Blackstein ME.

BMC Cancer. 2016 Jan 19;16:30. doi: 10.1186/s12885-016-2054-2.

8.

The GOLD ReGISTry: a Global, Prospective, Observational Registry Collecting Longitudinal Data on Patients with Advanced and Localised Gastrointestinal Stromal Tumours.

Barrios CH, Blackstein ME, Blay JY, Casali PG, Chacon M, Gu J, Kang YK, Nishida T, Purkayastha D, Woodman RC, Reichardt P.

Eur J Cancer. 2015 Nov;51(16):2423-33. doi: 10.1016/j.ejca.2015.07.010. Epub 2015 Aug 3.

9.

Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial.

Corless CL, Ballman KV, Antonescu CR, Kolesnikova V, Maki RG, Pisters PW, Blackstein ME, Blanke CD, Demetri GD, Heinrich MC, von Mehren M, Patel S, McCarter MD, Owzar K, DeMatteo RP.

J Clin Oncol. 2014 May 20;32(15):1563-70. doi: 10.1200/JCO.2013.51.2046. Epub 2014 Mar 17. Erratum in: J Clin Oncol. 2014 Oct 20;32(30):3462.

10.

Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial.

Demetri GD, Reichardt P, Kang YK, Blay JY, Rutkowski P, Gelderblom H, Hohenberger P, Leahy M, von Mehren M, Joensuu H, Badalamenti G, Blackstein M, Le Cesne A, Schöffski P, Maki RG, Bauer S, Nguyen BB, Xu J, Nishida T, Chung J, Kappeler C, Kuss I, Laurent D, Casali PG; GRID study investigators.

Lancet. 2013 Jan 26;381(9863):295-302. doi: 10.1016/S0140-6736(12)61857-1. Epub 2012 Nov 22.

11.

Topotecan and cyclophosphamide in adults with relapsed sarcoma.

Blanchette P, Hogg D, Ferguson P, Wunder JS, Swallow C, Gladdy R, Chung P, O'Sullivan B, Blackstein ME, Catton C, Gupta AA.

Sarcoma. 2012;2012:749067. doi: 10.1155/2012/749067. Epub 2012 Jul 18.

12.

A thematic review of scientific and family interests in Canavan Disease: where are the developmentalists?

Glicksman S, Borgen C, Blackstein M, Gordon A, Hanon I, Kusin D, Leibowitz B, Halle J.

J Intellect Disabil Res. 2013 Sep;57(9):815-25. doi: 10.1111/j.1365-2788.2012.01576.x. Epub 2012 Jun 8. Review.

PMID:
22676184
13.

Axial Skeletal Location Predicts Poor Outcome in Ewing's Sarcoma: A Single Institution Experience.

Weiss KR, Biau DJ, Bhumbra R, Griffin AM, Blackstein ME, Chung P, Catton C, O'Sullivan B, Ferguson PC, Wunder JS.

Sarcoma. 2011;2011:395180. doi: 10.1155/2011/395180. Epub 2011 Nov 24.

14.

Clinical features, treatment, and outcome in 102 adult and pediatric patients with localized high-grade synovial sarcoma.

Al-Hussaini H, Hogg D, Blackstein ME, O'Sullivan B, Catton CN, Chung PW, Griffin AM, Hodgson D, Hopyan S, Kandel R, Ferguson PC, Wunder JS, Gupta AA.

Sarcoma. 2011;2011:231789. doi: 10.1155/2011/231789. Epub 2011 Apr 14.

15.

Perspective on updated treatment guidelines for patients with gastrointestinal stromal tumors.

Blay JY, von Mehren M, Blackstein ME.

Cancer. 2010 Nov 15;116(22):5126-37. doi: 10.1002/cncr.25267. Review.

16.

Clinical outcome of children and adults with localized Ewing sarcoma: impact of chemotherapy dose and timing of local therapy.

Gupta AA, Pappo A, Saunders N, Hopyan S, Ferguson P, Wunder J, O'Sullivan B, Catton C, Greenberg M, Blackstein M.

Cancer. 2010 Jul 1;116(13):3189-94. doi: 10.1002/cncr.25144.

17.

Painful palatal swelling.

Klieb HB, Duchnay M, Skeete D, Leong IT, Blackstein ME.

Lancet. 2010 Apr 3;375(9721):1224. doi: 10.1016/S0140-6736(10)60053-0. No abstract available.

PMID:
20362816
18.

Circulating levels of soluble KIT serve as a biomarker for clinical outcome in gastrointestinal stromal tumor patients receiving sunitinib following imatinib failure.

Deprimo SE, Huang X, Blackstein ME, Garrett CR, Harmon CS, Schöffski P, Shah MH, Verweij J, Baum CM, Demetri GD.

Clin Cancer Res. 2009 Sep 15;15(18):5869-77. doi: 10.1158/1078-0432.CCR-08-2480. Epub 2009 Sep 8.

19.

Limitations of single slice dynamic contrast enhanced MR in pharmacokinetic modeling of bone sarcomas.

Toms AP, White LM, Kandel R, Bleakney RR, Noseworthy M, Lee S, Blackstein ME, Wunder J.

Acta Radiol. 2009 Jun;50(5):512-20. doi: 10.1080/02841850902922761.

PMID:
19431058
20.

Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial.

Dematteo RP, Ballman KV, Antonescu CR, Maki RG, Pisters PW, Demetri GD, Blackstein ME, Blanke CD, von Mehren M, Brennan MF, Patel S, McCarter MD, Polikoff JA, Tan BR, Owzar K; American College of Surgeons Oncology Group (ACOSOG) Intergroup Adjuvant GIST Study Team.

Lancet. 2009 Mar 28;373(9669):1097-104. doi: 10.1016/S0140-6736(09)60500-6. Epub 2009 Mar 18. Erratum in: Lancet. 2009 Aug 8;374(9688):450.

Supplemental Content

Loading ...
Support Center